CNTN3

CNTN3 is a GPI-anchored immunoglobulin superfamily cell adhesion molecule containing six Ig-like domains and four fibronectin type III repeats that promotes neurite outgrowth in vitro and is expressed in a cell type-specific pattern in brain neurons including Purkinje cells, dentate gyrus granule cells, and CA1 pyramidal cells (PMID:8060619, PMID:8586965). Its second fibronectin type III domain (Fn2) directly binds the copper-binding domain of amyloid precursor protein (APP), with key contact residues mapped by alanine-scanning mutagenesis (PMID:31318883). In a non-neuronal context, CNTN3 transcription is driven by PRRX2 binding to its promoter, and CNTN3 promotes epithelial-to-mesenchymal transition, migration, invasion, and tumor growth in colorectal cancer cells (PMID:41882765).

1. 1994 High

   Establishing that CNTN3 is a neurite outgrowth-promoting GPI-anchored Ig superfamily member answered the basic question of what molecular class this gene encodes and what neural function it supports.

   Evidence cDNA cloning with domain analysis and in vitro neurite outgrowth assay using recombinant BIG-1 protein as substrate for cultured neurons

   PMID:8060619 PMID:8108413

   Open questions at the time

   • In vivo loss-of-function or gain-of-function studies not performed
   • Receptor or co-receptor mediating neurite outgrowth signal not identified
   • Mechanism by which GPI-anchored CNTN3 transduces a signal across the membrane unknown
2. 1995 High

   Demonstrating that the related BIG-2 isoform also promotes neurite outgrowth and mapping its distinct expression pattern (e.g., CA1 pyramidal cells) established that contactin family members have overlapping biochemical activities but spatially segregated expression domains in the brain.

   Evidence Recombinant BIG-2 neurite outgrowth assay and in situ hybridization comparing BIG-1, BIG-2, TAG-1, and F3 expression

   PMID:8586965

   Open questions at the time

   • Functional redundancy versus specificity among contactin family members not tested
   • Ligand or cis-interacting partner mediating neurite outgrowth not identified
3. 2019 High

   Mapping the CNTN3-APP binding interface to the Fn2 domain of CNTN3 and the copper-binding domain of APP answered a long-standing question about the molecular partners of CNTN3 and provided a candidate trans-synaptic signaling axis.

   Evidence In vitro binding assays with alkaline phosphatase and Fc fusion proteins combined with systematic alanine-scanning mutagenesis

   PMID:31318883

   Open questions at the time

   • Functional consequence of CNTN3-APP interaction on APP processing or neuronal signaling not determined
   • Whether the interaction occurs in trans (cell-cell) or in cis on the same membrane not resolved
   • In vivo relevance of the CNTN3-APP interaction not tested
4. 2026 Medium

   Identifying PRRX2 as a direct transcriptional activator of CNTN3 and showing that CNTN3 promotes EMT, invasion, and tumor growth in colorectal cancer revealed a non-neuronal oncogenic role and an upstream regulatory mechanism.

   Evidence ChIP and dual-luciferase reporter assays for PRRX2-promoter binding; knockdown/rescue experiments, proliferation/apoptosis/migration/invasion assays, EMT marker detection, and xenograft tumor model in colorectal cancer cells

   PMID:41882765

   Open questions at the time

   • Findings from a single laboratory; independent replication in additional cancer cohorts needed
   • Downstream signaling pathway through which CNTN3 promotes EMT not defined
   • Whether the GPI-anchored form or a shed soluble form mediates the oncogenic phenotype is unknown

• The in vivo neuronal function of CNTN3 — including phenotypes of knockout animals, the signaling consequence of CNTN3-APP interaction, and how CNTN3 transduces signals across the membrane as a GPI-anchored protein — remains uncharacterized.
• No knockout or conditional knockout phenotype reported
• No identified transmembrane co-receptor or signaling adaptor for CNTN3
• Structural basis of the CNTN3-APP complex not solved